AAAAAA
Results:
1-15
|
Results: 15
Authors:
Morin, D
Hauet, T
Spedding, M
Tillement, JP
Citation: D. Morin et al., Mitochondria as target for antiischemic drugs, ADV DRUG DE, 49(1-2), 2001, pp. 151-174
Authors:
Kovacs, A
Gyonos, I
Magyar, J
Banyasz, T
Nanasi, PP
Spedding, M
Szenasi, G
Citation: A. Kovacs et al., Effects of EGIS-7229 (S 21407), a novel class III antiarrhythmic drug, on myocardial refractoriness to electrical stimulation in vivo and in vitro, J CARDIO PH, 37(1), 2001, pp. 78-88
Authors:
Morris, RGM
Kelly, S
Burney, D
Anthony, T
Boyer, PA
Spedding, M
Citation: Rgm. Morris et al., Tianeptine and its enantiomers: effects on spatial memory in rats with medial septum lesions, NEUROPHARM, 41(2), 2001, pp. 272-281
Authors:
Milligan, G
Kellett, E
Dacquet, C
Dubreuil, V
Jacoby, E
Millan, MJ
Lavielle, G
Spedding, M
Citation: G. Milligan et al., S 14506: novel receptor coupling at 5-HT1A receptors, NEUROPHARM, 40(3), 2001, pp. 334-344
Authors:
Largeron, M
Mesples, B
Gressens, P
Cecchelli, R
Spedding, M
Le Ridant, A
Fleury, MB
Citation: M. Largeron et al., The neuroprotective activity of 8-alkylamino-1,4-benzoxazine antioxidants, EUR J PHARM, 424(3), 2001, pp. 189-194
Authors:
Spedding, M
Evrard, P
Gressens, P
Citation: M. Spedding et al., Neuroprotection in the newborn infant: interactions between stress, glutamate, glucocorticoids and development, DEVELOP MED, 43, 2001, pp. 10-12
Authors:
Spedding, M
Menton, K
Markham, A
Weetman, DF
Citation: M. Spedding et al., Antagonists and the purinergic nerve hypothesis: 2,2 '-pyridylisatogen tosylate (PIT), an allosteric modulator of P2Y receptors. A retrospective on aquarter century of progress, J AUTON NER, 81(1-3), 2000, pp. 225-227
Authors:
Rosen, GM
Tsai, P
Barth, ED
Dorey, G
Casara, P
Spedding, M
Halpern, HJ
Citation: Gm. Rosen et al., A one-step synthesis of 2-(2-pyridyl)-3H-indol-3-one N-oxide: Is it an efficient spin trap for hydroxyl radical?, J ORG CHEM, 65(14), 2000, pp. 4460-4463
Authors:
Jacoby, E
Fauchere, JL
Raimbaud, E
Ollivier, S
Michel, A
Spedding, M
Citation: E. Jacoby et al., A three binding site hypothesis for the interaction of ligands with monoamine G protein-coupled receptors: Implications for combinatorial ligand design, QSAR, 18(6), 1999, pp. 561-572
Authors:
Auwerx, J
Baulieu, E
Beato, M
Becker-Andre, M
Burbach, PH
Camerino, G
Chambon, P
Cooney, A
Dejean, A
Dreyer, C
Evans, RM
Gannon, F
Giguere, V
Gronemeyer, H
Gustafson, JA
Laudet, V
Lazar, MA
Mangelsdorf, DJ
Milbrandt, J
Milgrom, E
Moore, DD
O'Malley, B
Parker, M
Parker, K
Perlmann, T
Pfahl, M
Rosenfeld, MG
Samuels, H
Schutz, G
Sladek, FM
Stunnenberg, HG
Spedding, M
Thummel, C
Tsai, MJ
Umesono, K
Vennstrom, B
Wahli, W
Weinberger, C
Willson, TM
Yamamoto, K
Citation: J. Auwerx et al., A unified nomenclature system for the nuclear receptor superfamily, CELL, 97(2), 1999, pp. 161-163
Authors:
Spedding, M
Tillement, JP
Morin, D
Le Ridant, A
Citation: M. Spedding et al., Mitochondria as targets for drugs: effects of trimetazidine, THERAPIE, 54(5), 1999, pp. 627-635
Authors:
Volonte, C
Ciotti, MT
D'Ambrosi, N
Lockhart, B
Spedding, M
Citation: C. Volonte et al., Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones, NEUROPHARM, 38(9), 1999, pp. 1335-1342
Authors:
Sebban, C
Zhang, XQ
Tesolin-Decros, B
Millan, MJ
Spedding, M
Citation: C. Sebban et al., Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission, BR J PHARM, 128(5), 1999, pp. 1045-1054
Authors:
Sebban, C
Tesolin-Decros, B
Millan, MJ
Spedding, M
Citation: C. Sebban et al., Contrasting EEG profiles elicited by antipsychotic agents in the prefrontal cortex of the conscious rat: antagonism of the effects of clozapine by modafinil, BR J PHARM, 128(5), 1999, pp. 1055-1063
Authors:
Spedding, M
Citation: M. Spedding, Sodium and calcium channel modulators in stroke therapy, STROKE THERAPY, 1999, pp. 157-193
Risultati:
1-15
|